Tandys

Tandys describes itself as a growth-stage private equity firm, which in practice means it targets later-stage companies that have demonstrated product-market fit and are raising capital primarily for expansion — sales team buildout, geographic entry, or scaling operations — rather than for product development or initial go-to-market validation. The firm does not label itself as a venture capital or buyout shop. Without a detailed strategy document or published portfolio, the exact check-size range is not publicly available.

Tandys has not published an explicit sector-avoidance list, which is not unusual for a firm that does not market heavily to outside allocators. Growth-equity firms in its geography most commonly avoid capital-intensive industries like heavy manufacturing, upstream energy, and regulated biotech, but no statement from Tandys itself confirms any exclusion. An allocator must map this during a direct conversation.

No co-investment track record, co-investor names, or co-investment policy has been disclosed by Tandys in any public medium. Growth-equity firms of this profile sometimes offer co-investment rights to their limited partners on a deal-by-deal basis, but Tandys has not confirmed or denied this practice. An LP evaluating a potential commitment should raise the question of co-investment capacity and historical allocation during the operational-due-diligence phase.